 |
|
Presenilin 1 Mutation in an African American Family Presenting With Atypical Alzheimer Dementia
Gregory A. Rippon, MD;
Richard Crook, BSc;
Matthew Baker, BSc;
Elizabeth Halvorsen, MD;
Steven Chin, MD, PhD;
Michael Hutton, PhD;
Henry Houlden, MD;
John Hardy, PhD;
Timothy Lynch, BSc, FRCP, FRCPI
Arch Neurol. 2003;60:884-888.
Background Alzheimer disease (AD) is characterized by memory and visuospatial deficits with relative sparing of personality. Mutations in 3 genes (presenilin 1 and 2 and amyloid precursor protein) are associated with presenile AD. Presenilin 1 gene mutations have not been described in African Americans.
Methods We studied an African American family with autosomal dominant rapidly progressive dementia and psychosis occurring early in the fifth decade of life. We performed neurologic evaluations, psychometrics, and neuroimaging. We sequenced the amyloid precursor protein gene, presenilin 1 and 2, and tau in affected and unaffected family members. One patient underwent a brain biopsy and subsequent autopsy.
Results Personality change, auditory and visual hallucinations, delusions, memory impairment, word-finding difficulties, and subsequent rigidity, dystonia, myoclonus, and mutism developed in 2 brothers. Neuropsychometric testing in one was consistent with frontotemporal dementia or atypical AD. Neuroimaging studies showed diffuse cortical involvement. A clinical diagnosis of familial non-Alzheimer dementia was made. However, results of temporal lobe biopsy in one revealed amyloid neuritic plaques, and autopsy results confirmed the diagnosis of AD. Gene sequencing revealed a presenilin 1 point mutation (M139V) cosegregating with the disease. A tau polymorphism in exon 7 (A178T) was found in an affected brother and unaffected relatives.
Conclusions We report the first documented presenilin mutation in African American patients presenting with early personality change, psychosis, and memory loss with preserved praxis. The M139V mutation can present differently between kindreds, with some features suggestive of a frontal lobe syndrome. The M139V mutation can lead to atypical AD, and genetic background may have a role in determining the phenotype of genetically defined AD.
From the Department of Neurology, Mayo Clinic, Rochester, Minn (Dr Rippon); Department of Neuroscience, Mayo Clinic Jacksonville, Jacksonville, Fla (Messrs Crook and Baker and Drs Hutton, Houlden, and Hardy); the Department of Psychiatry, Mount Sinai Medical Center, New York, NY (Dr Halvorsen); the Departments of Pathology (Dr Chin) and Neurology (Drs Rippon and Lynch), Columbia University College of Physicians and Surgeons, New York; and the Department of Neurology, The Mater Misericordiae and Beaumont Hospitals, University College, Dublin, Ireland (Dr Lynch).
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Familial Early-Onset Dementia With Tau Intron 10 + 16 Mutation With Clinical Features Similar to Those of Alzheimer Disease
Doran et al.
Arch Neurol 2007;64:1535-1539.
ABSTRACT
| FULL TEXT
Frontotemporal dementia-like phenotypes associated with presenilin-1 mutations.
Mendez and McMurtray
AM J ALZHEIMERS DIS OTHER DEMEN 2006;21:281-286.
ABSTRACT
An African American family with early-onset Alzheimer disease and an APP (T714I) mutation
Edwards-Lee et al.
Neurology 2005;64:377-379.
ABSTRACT
| FULL TEXT
Genotype-Phenotype Correlation in Early-onset Alzheimer Disease With Presenilin 1 Gene Mutations
Larner
Arch Neurol 2004;61:801-801.
FULL TEXT
|
